Organogenesis Holdings (ORGO) Assets (2015 - 2026)

Organogenesis Holdings' Assets history runs 12 years deep, the most recent figure standing at $520.0 million for Q1 2026.

• In Q1 2026, Assets rose 11.25% year-over-year to $520.0 million; the TTM figure through Mar 2026 stood at $520.0 million (up 11.25% YoY), while the FY2025 annual figure was $598.7 million, up 20.25% from the prior year.
• Assets was $520.0 million for Q1 2026 at Organogenesis Holdings, down from $598.7 million in the prior quarter.
• In the past five years, Assets ranged from a high of $598.7 million in Q4 2025 to a low of $436.3 million in Q1 2022.
• Historically, Assets has averaged $471.8 million across 5 years, with a median of $458.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets surged 36.68% in 2022, then declined 3.53% in 2024.
• A 5-year view of Assets shows it stood at $449.4 million in 2022, then increased by 2.37% to $460.0 million in 2023, then grew by 8.23% to $497.9 million in 2024, then advanced by 20.25% to $598.7 million in 2025, then retreated by 13.15% to $520.0 million in 2026.
• The last three Assets figures came in at $520.0 million (Q1 2026), $598.7 million (Q4 2025), and $509.8 million (Q3 2025), per Business Quant data.